 |
|
|
| |
FSS and SF-36 in Asian Patients with HCV Genotype 1b Receiving Daclatasvir and Asunaprevir and who are Interferon plus Ribavarin Intolerant or Ineligible
|
| |
| |
Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2016). Tokyo, Japan, February 20-24, 2016
Mo L,1 Wygant G,2 Treitel M,2 Bhore R,2 Torbeyns A3
1Bristol-Myers Squibb, Shanghai, China; 2Bristol-Myers Squibb Research and Development, Princeton, USA;
3 Bristol-Myers Squibb, Braine-l'Alleud, Belgium
|
| |
|
|
|
|
|
